The U.S, Court of Appeals for the Federal Circuit (CAFC) on Monday, January 6, rejected Laboratory Corporation of America Holdings’ (Labcorp) argument that, among other issues, the Patent Trial and Appeal Board (PTAB) erred in its motivation to combine analysis and ultimate determination that Labcorp had not proven Ravgen, Inc.’s patent claims to be obvious. The opinion was authored by Judge Lourie.
Recent Posts
- EU Publishes Code of Practice as Deadline for AI Act’s Provisions on General-Purpose AI Models Nears
- Will the Federal Circuit Finally Follow Supreme Court Holdings on the Unavailability of the Laches Defense?
- CAFC Upholds Win for Janssen on Patent for Antipsychotic Med Dosing Regimen
- IP Innovators – From Patent Office to Managing Partner: Chris Agrawal’s Journey
- In Sonos v. Google, the Federal Circuit Has a Chance to Fix Its Prosecution Laches Doctrine